| CASE REPORT |
|
| Year : 2020 | Volume
: 11
| Issue : 2 | Page : 77-79 |
|
|
Valproic acid for the treatment of refractory pediatric primary bone anaplastic large-cell lymphoma: A case report and literature review
Randa I Al-Bloushy1, Salma H Sait1, Ali H Algiraigri2
1 Department of Hematology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia
2 Department of Hematology, King Abdulaziz University Hospital; King Faisal Special Hospital and Research Center, Jeddah, Saudi Arabia
Correspondence Address:
Dr. Ali H Algiraigri
Department of Hematology, King Abdulaziz University Hospital, Jeddah 22252
Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/joah.joah_3_20
|
|
|
Primary bony anaplastic large-cell lymphoma is quite rare in children but potentially life-threatening lymphoma. Such disease is challenging and often carries a poor prognosis. Here, we report a patient who presented with an aggressive bony lymphoma and failed to respond to conventional chemotherapy; however, he had a robust response to valproic acid, which changed his status from hopeless palliative case to a success story and allowed him to complete his intended chemotherapy protocol.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
